Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$1.12 +0.03 (+2.75%)
As of 06/23/2025

DHAC vs. BRTX, MGRX, SSY, OTRK, BGLC, ATIP, ACON, VSEE, NIVF, and BACK

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include Biorestorative Therapies (BRTX), Mangoceuticals (MGRX), SunLink Health Systems (SSY), Ontrak (OTRK), BioNexus Gene Lab (BGLC), ATI Physical Therapy (ATIP), Aclarion (ACON), VSee Health (VSEE), NewGenIvf Group (NIVF), and IMAC (BACK). These companies are all part of the "healthcare" industry.

Digital Health Acquisition vs. Its Competitors

Digital Health Acquisition (NASDAQ:DHAC) and Biorestorative Therapies (NASDAQ:BRTX) are both small-cap services companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, community ranking, valuation, dividends and risk.

Digital Health Acquisition has higher earnings, but lower revenue than Biorestorative Therapies.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Digital Health AcquisitionN/AN/AN/AN/AN/A
Biorestorative Therapies$400K31.97-$8.98M-$1.47-1.16

Biorestorative Therapies received 2 more outperform votes than Digital Health Acquisition when rated by MarketBeat users.

CompanyUnderperformOutperform
Digital Health AcquisitionN/AN/A
Biorestorative TherapiesOutperform Votes
2
100.00%
Underperform Votes
No Votes

Biorestorative Therapies has a consensus price target of $18.00, indicating a potential upside of 955.72%. Given Biorestorative Therapies' stronger consensus rating and higher possible upside, analysts clearly believe Biorestorative Therapies is more favorable than Digital Health Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Digital Health Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Biorestorative Therapies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

1.0% of Digital Health Acquisition shares are held by institutional investors. Comparatively, 69.4% of Biorestorative Therapies shares are held by institutional investors. 6.6% of Digital Health Acquisition shares are held by insiders. Comparatively, 25.5% of Biorestorative Therapies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, Biorestorative Therapies had 3 more articles in the media than Digital Health Acquisition. MarketBeat recorded 3 mentions for Biorestorative Therapies and 0 mentions for Digital Health Acquisition. Digital Health Acquisition's average media sentiment score of 0.67 beat Biorestorative Therapies' score of 0.50 indicating that Digital Health Acquisition is being referred to more favorably in the media.

Company Overall Sentiment
Digital Health Acquisition Positive
Biorestorative Therapies Positive

Digital Health Acquisition has a net margin of 0.00% compared to Biorestorative Therapies' net margin of -3,093.61%. Digital Health Acquisition's return on equity of 0.00% beat Biorestorative Therapies' return on equity.

Company Net Margins Return on Equity Return on Assets
Digital Health AcquisitionN/A N/A N/A
Biorestorative Therapies -3,093.61%-129.47%-86.02%

Digital Health Acquisition has a beta of 0.23, suggesting that its share price is 77% less volatile than the S&P 500. Comparatively, Biorestorative Therapies has a beta of 76.87, suggesting that its share price is 7,587% more volatile than the S&P 500.

Summary

Biorestorative Therapies beats Digital Health Acquisition on 9 of the 13 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices IndustryServices SectorNASDAQ Exchange
Market Cap$4.04M$174.15M$278.38M$8.72B
Dividend YieldN/A5.41%N/A4.23%
P/E RatioN/A2.47N/A19.53
Price / SalesN/A406.682.30109.48
Price / CashN/A74.78N/A26.73
Price / BookN/A6.076.435.72
Net IncomeN/A$3.67M-$920K$248.44M
7 Day Performance5.66%-0.96%8.54%2.33%
1 Month Performance2.75%4.84%12.87%5.79%
1 Year Performance-90.75%60.65%42.44%16.82%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$1.12
+2.8%
N/A-90.6%$4.04MN/A0.002,021Gap Up
High Trading Volume
BRTX
Biorestorative Therapies
3.7584 of 5 stars
$1.70
-1.2%
$18.00
+958.8%
-19.2%$12.75M$400K-1.167Buyback Announcement
MGRX
Mangoceuticals
0.3882 of 5 stars
$1.97
+1.5%
N/A-97.6%$10.19M$620K-0.423Gap Up
SSY
SunLink Health Systems
1.9249 of 5 stars
$0.97
-2.4%
N/A+63.7%$6.84M$31.09M6.941,376News Coverage
Gap Up
OTRK
Ontrak
2.2163 of 5 stars
$1.39
flat
$45.00
+3,137.4%
-60.2%$5.87M$10.85M-0.09250News Coverage
BGLC
BioNexus Gene Lab
0.1275 of 5 stars
$2.93
+1.7%
N/A-40.8%$5.27M$9.51M0.0030News Coverage
ATIP
ATI Physical Therapy
N/A$1.00
-2.9%
N/A-82.7%$4.41M$741.86M-0.055,600
ACON
Aclarion
2.9248 of 5 stars
$7.33
-0.3%
$11,758.50
+160,316.1%
-99.7%$4.25M$50K0.007News Coverage
VSEE
VSee Health
1.6188 of 5 stars
$1.10
+6.8%
$5.00
+354.5%
N/A$3.96M$6.38M0.00N/ANews Coverage
Gap Up
NIVF
NewGenIvf Group
N/A$1.24
-0.8%
N/A-99.5%$657K$5.43M0.00N/AGap Down
BACK
IMAC
N/A$0.05
+3.7%
N/A-97.6%$94K$72.05K0.00180Gap Up

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 6/24/2025 by MarketBeat.com Staff
From Our Partners